For the first time, scientists discover that a subset of a common blood cancer is more deadly in women than in men — and find a new targeted treatment approach
Dr. Manel Esteller, director of the Josep Carreras Leukaemia Research Institute, recognized among the researchers with the most scientific impact according to Stanford University